For global medical device manufacturers, entering multiple markets requires a clear understanding of different regulatory systems.

Three of the most important markets—South Korea, the United States, and the European Union—are governed by: --> MFDS (South Korea) --> FDA (United States) --> EU MDR (European Union)

Each system has unique requirements for classification, approval, clinical data, and quality management.

In this guide, we compare Korea vs US FDA vs EU MDR to help you plan a successful global regulatory strategy.

Overview of Regulatory Authorities --> South Korea: Ministry of Food and Drug Safety (MFDS) --> United States: Food and Drug Administration (FDA) --> European Union: MDR framework with Notified Bodies

Key Differences – At a Glance

Device Classification Comparison

South Korea (MFDS) Class I (low risk) to Class IV (high risk) Risk-based classification

US FDA Class I, II, III Based on intended use and risk

EU MDR Class I, IIa, IIb, III More detailed classification rules

Approval Pathways

1. South Korea (MFDS) Technical file submission KGMP certification Clinical data (if required)

2. US FDA 510(k): Substantial equivalence De Novo: New devices PMA: High-risk devices

3. EU MDR CE marking via Notified Body Technical documentation (Annex II & III) Clinical evaluation

Approval Timeline Comparison

👉 South Korea is often considered a faster approval market

Clinical Data Requirements

👉 EU MDR has the strictest clinical evidence requirements

Quality Management System (QMS) Korea: KGMP certification required US FDA: Quality System Regulation (QSR) EU MDR: ISO 13485 mandatory

Local Representation Requirements

Key Challenges by Region

1. South Korea Korean language requirement KGMP certification

2. US FDA Complex approval pathways Strict regulatory review

3. EU MDR High documentation burden Limited notified bodies

Which Market is Best for First Entry?

Choose South Korea if: You want faster approval You already have ISO 13485 You want entry into Asia

Choose US FDA if: You target global credibility You have predicate devices

Choose EU MDR if: You want access to multiple EU countries You have strong clinical data

Global Regulatory Strategy (Recommended Approach) 1. Start with FDA or EU MDR (global credibility) 2. Expand to South Korea for fast commercialization 3. Use harmonized documentation across regions

How OMC Medical Can Help

OMC Medical offers multi-country regulatory support, including:

✔ South Korea (MFDS approval & KGMP)
✔ USA (FDA 510(k), PMA, De Novo)
✔ Europe (EU MDR CE Marking)
✔ Global regulatory strategy

👉 We help manufacturers enter multiple markets efficiently

📞 Get Expert Support

Planning global market entry?

Contact OMC Medical today for end-to-end regulatory consulting.